Max Healthcare Institute Limited has informed the Exchange regarding a press release dated November 14, 2025, titled "Max Healthcare Q2 revenue soars to ₹ 2,692 Cr, registering growth of +21% YoY; Network Operating EBITDA grows to ₹ 694 Cr, +23% YoY; PAT grows by +59% YoY to ₹ 554 Cr".
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty 100 and 1.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Max Healthcare reported Q2 FY26 revenue of ₹2,692 Cr, up 21% year-on-year, driven by strong performance across its hospital network. Network Operating EBITDA grew 23% YoY to ₹694 Cr, outpacing revenue growth and indicating improved operating leverage. Profit after tax (PAT) surged 59% YoY to ₹554 Cr, reflecting strong bottom-line growth on the back of higher revenues and likely operational efficiencies. The results highlight sustained momentum in the hospital business with broad-based growth across metrics.
This is a clearly positive earnings update — revenue growth above 20%, double-digit EBITDA expansion, and near 60% PAT growth signal strong operational performance and are likely to be viewed favorably by the market, potentially supporting the stock price.